A detailed history of Nomura Asset Management CO LTD transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 65,033 shares of DNLI stock, worth $1.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
65,033
Previous 0 Infinity%
Holding current value
$1.58 Million
Previous $0 Infinity%
% of portfolio
0.01%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$20.96 - $31.05 $1.36 Million - $2.02 Million
65,033 New
65,033 $1.89 Million
Q2 2024

Aug 14, 2024

BUY
$14.96 - $23.22 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024

BUY
$15.83 - $23.35 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024

BUY
$16.2 - $23.18 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023

BUY
$20.63 - $30.17 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023

BUY
$23.37 - $32.96 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023

BUY
$21.91 - $32.67 $0 - $0
0 New
0 $0
Q4 2022

Feb 14, 2023

BUY
$26.28 - $33.92 $0 - $0
0 New
0 $0
Q3 2022

Nov 14, 2022

BUY
$25.97 - $38.53 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022

BUY
$25.97 - $38.53 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022

BUY
$25.97 - $38.53 $0 - $0
0 New
0 $0
Q2 2022

Aug 12, 2022

BUY
$20.88 - $35.19 $0 - $0
0 New
0 $0
Q1 2022

May 13, 2022

SELL
$29.0 - $47.27 $301,658 - $491,702
-10,402 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$42.59 - $55.02 $443,021 - $572,318
10,402 New
10,402 $464,000
Q3 2021

Nov 12, 2021

SELL
$48.48 - $78.23 $349,540 - $564,038
-7,210 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$53.8 - $81.53 $387,898 - $587,831
7,210 New
7,210 $412,000
Q4 2020

Feb 12, 2021

BUY
$36.89 - $93.56 $0 - $0
0 New
0 $0
Q3 2020

Nov 12, 2020

BUY
$23.13 - $38.84 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$16.01 - $28.82 $0 - $0
0 New
0 $0
Q1 2020

May 14, 2020

BUY
$14.2 - $27.98 $0 - $0
0 New
0 $0
Q4 2019

Feb 13, 2020

BUY
$14.4 - $19.99 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$15.32 - $21.92 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019

BUY
$18.5 - $28.14 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019

BUY
$17.99 - $24.65 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019

BUY
$17.99 - $24.65 $0 - $0
0 New
0 $0

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.27B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.